← Back to Search

Other

Omega-3 Fatty Acids for Preventing Breast Cancer

N/A

Waitlist Available

Research Sponsored by Cedars-Sinai Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Performance status SWOG 0-1

Not eligible for or refused standard breast cancer risk reduction strategies (e.g., prophylactic oophorectomy, prophylactic mastectomy, or tamoxifen)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial is testing if omega-3 fatty acids can prevent breast cancer in women who are at high risk of developing it.

Who is the study for?

This trial is for women at high risk of breast cancer due to family history, genetic factors like BRCA mutations, or personal medical history. Participants should have a significant chance of developing breast cancer and not be pregnant or nursing. They must also meet specific health criteria regarding liver, kidney, and blood cell counts.Check my eligibility

What is being tested?

The study is testing the effectiveness of omega-3 fatty acids in preventing the development or recurrence of breast cancer in high-risk women. It's a randomized trial which means participants will be randomly assigned to receive either omega-3 supplements or a placebo for comparison.See study design

What are the potential side effects?

While the side effects are not detailed here, common side effects associated with omega-3 supplements can include fishy aftertaste, upset stomach, and nausea. More serious side effects are rare but could involve bleeding if taken in high doses.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am fully active or restricted in physically strenuous activity but can do light work.

Select...

I have not had, or have chosen not to have, preventive breast cancer surgery or take tamoxifen.

Select...

I am 18 years old or older.

Select...

I haven't had any cancer except for nonmelanoma skin cancer in the last 5 years.

Select...

My recent mammogram showed no signs of cancer.

Select...

I am female.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Breast density as measured by the Madena method at 1 year

0 / 6Eligibility criteria met

Find a Location

Who is running the clinical trial?

Cedars-Sinai Medical CenterLead Sponsor

499 Previous Clinical Trials

164,777 Total Patients Enrolled

16 Trials studying Breast Cancer

2,044 Patients Enrolled for Breast Cancer

Agustin Garcia, MDStudy ChairCedars-Sinai Medical Center

11 Previous Clinical Trials

219 Total Patients Enrolled

2 Trials studying Breast Cancer

100 Patients Enrolled for Breast Cancer

Media Library

Omega-3 Fatty Acids (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00114296 — N/A

Breast Cancer Clinical Trial 2023: Omega-3 Fatty Acids Highlights & Side Effects. Trial Name: NCT00114296 — N/A

Omega-3 Fatty Acids (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00114296 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment still open to more participants?

"The clinicaltrials.gov website indicates that this trial, initially posted on April 1st 2005, is not currently calling for participants. Nonetheless, there are presently 2602 other active trials where one can volunteer as a participant."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

2005. "Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00114296.

All > Breast Cancer Hawaii > Breast